BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21862514)

  • 1. Effects of dexamethasone-loaded PLGA microspheres on human fetal osteoblasts.
    Dawes GJ; Fratila-Apachitei LE; Necula BS; Apachitei I; van Leeuwen JP; Duszczyk J; Eijken M
    J Biomater Appl; 2012 Nov; 27(4):477-83. PubMed ID: 21862514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug release from PLGA microspheres attached to solids using supercritical CO₂.
    Mulia K; Witkamp GJ; Dawes GJ; Fratila-Apachitei LE; Apachitei I; Duszczyk J; Pellikaan H
    J Biomater Appl; 2011 Jan; 25(5):401-12. PubMed ID: 20042430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimising the controlled release of dexamethasone from a new generation of PLGA-based microspheres intended for intravitreal administration.
    Rodríguez Villanueva J; Bravo-Osuna I; Herrero-Vanrell R; Molina Martínez IT; Guzmán Navarro M
    Eur J Pharm Sci; 2016 Sep; 92():287-97. PubMed ID: 26987610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo evaluation of a dexamethasone/PLGA microsphere system designed to suppress the inflammatory tissue response to implantable medical devices.
    Hickey T; Kreutzer D; Burgess DJ; Moussy F
    J Biomed Mater Res; 2002 Aug; 61(2):180-7. PubMed ID: 12007197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Porous hydroxyapatite scaffold with three-dimensional localized drug delivery system using biodegradable microspheres.
    Son JS; Appleford M; Ong JL; Wenke JC; Kim JM; Choi SH; Oh DS
    J Control Release; 2011 Jul; 153(2):133-40. PubMed ID: 21420453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of a composite drug delivery system to prolong functionality of cell-based scaffolds.
    Murua A; Herran E; Orive G; Igartua M; Blanco FJ; Pedraz JL; Hernández RM
    Int J Pharm; 2011 Apr; 407(1-2):142-50. PubMed ID: 21094235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and in vitro evaluation of biocompatible dexamethasone-loaded nanoparticle dispersions, obtained from nano-emulsions, for inhalatory therapy.
    Fornaguera C; Llinàs M; Solans C; Calderó G
    Colloids Surf B Biointerfaces; 2015 Jan; 125():58-64. PubMed ID: 25437064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raloxifene-/raloxifene-poly(ethylene glycol) conjugate-loaded microspheres: A novel strategy for drug delivery to bone forming cells.
    Kavas A; Keskin D; Altunbaş K; Tezcaner A
    Int J Pharm; 2016 Aug; 510(1):168-83. PubMed ID: 27343363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine.
    Bae SE; Son JS; Park K; Han DK
    J Control Release; 2009 Jan; 133(1):37-43. PubMed ID: 18838089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation, characterization, and in vitro evaluation of physostigmine-loaded poly(ortho ester) and poly(ortho ester)/poly(D,L-lactide-co-glycolide) blend microspheres fabricated by spray drying.
    Wang L; Chaw CS; Yang YY; Moochhala SM; Zhao B; Ng S; Heller J
    Biomaterials; 2004 Jul; 25(16):3275-82. PubMed ID: 14980422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A protein/antibiotic releasing poly(lactic-co-glycolic acid)/lecithin scaffold for bone repair applications.
    Shi X; Wang Y; Ren L; Huang W; Wang DA
    Int J Pharm; 2009 May; 373(1-2):85-92. PubMed ID: 19429292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro characterization of vascular endothelial growth factor and dexamethasone releasing hydrogels for implantable probe coatings.
    Norton LW; Tegnell E; Toporek SS; Reichert WM
    Biomaterials; 2005 Jun; 26(16):3285-97. PubMed ID: 15603824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodegradable PLGA microcarriers for injectable delivery of chondrocytes: effect of surface modification on cell attachment and function.
    Chun KW; Yoo HS; Yoon JJ; Park TG
    Biotechnol Prog; 2004; 20(6):1797-801. PubMed ID: 15575714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characteristics of interferon-alpha poly(lactic-co-glycolic acid) microspheres.
    Yang F; Song FL; Pan YF; Wang ZY; Yang YQ; Zhao YM; Liang SZ; Zhang YM
    J Microencapsul; 2010; 27(2):133-41. PubMed ID: 20121486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microsphere-based drug releasing scaffolds for inducing osteogenesis of human mesenchymal stem cells in vitro.
    Shi X; Wang Y; Varshney RR; Ren L; Gong Y; Wang DA
    Eur J Pharm Sci; 2010 Jan; 39(1-3):59-67. PubMed ID: 19895885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release of PLGA-encapsulated dexamethasone from microsphere loaded porous surfaces.
    Dawes GJ; Fratila-Apachitei LE; Necula BS; Apachitei I; Witkamp GJ; Duszczyk J
    J Mater Sci Mater Med; 2010 Jan; 21(1):215-21. PubMed ID: 19669866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymeric "smart" coatings to prevent foreign body response to implantable biosensors.
    Wang Y; Papadimitrakopoulos F; Burgess DJ
    J Control Release; 2013 Aug; 169(3):341-7. PubMed ID: 23298616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of in vivo-in vitro release of dexamethasone from PLGA microspheres.
    Zolnik BS; Burgess DJ
    J Control Release; 2008 Apr; 127(2):137-45. PubMed ID: 18282629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fabrication of core-shell microcapsules using PLGA and alginate for dual growth factor delivery system.
    Choi DH; Park CH; Kim IH; Chun HJ; Park K; Han DK
    J Control Release; 2010 Oct; 147(2):193-201. PubMed ID: 20647022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The preservation of phenotype and functionality of dendritic cells upon phagocytosis of polyelectrolyte-coated PLGA microparticles.
    Fischer S; Uetz-von Allmen E; Waeckerle-Men Y; Groettrup M; Merkle HP; Gander B
    Biomaterials; 2007 Feb; 28(6):994-1004. PubMed ID: 17118442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.